Citigroup (NYSE:C) is under investigation by the Department of Justice, the Federal Bureau of Investigation, and the Internal ...

Citigroup Inc. Chief Executive Officer Jane Fraser said that clients who’d been waiting on the sidelines to do deals are ...

Citigroup CEO Jane Fraser sees a surge in M&A activity post-Trump win, with clients eager to make deals and capitalize on ...

The post-election rally in US stocks could run out of steam as investors start to take profits, according to strategists at ...

Citi raised the firm’s price target on Corpay (CPAY) to $430 from $405 and keeps a Buy rating on the shares post the Q3 report. The ...

Trump's promise of light regulation could solve one of Citi's biggest problems.

Vis Raghavan, the man charged with reviving Citigroup’s reputation as an investment bank, is setting his sights on the buyout kings. The former JPMorgan executive wants dealmakers to advise on, and ...

Citigroup has made substantial progress in the years, but the bank is still struggling with data quality provided to the regulators. Regardless, Citigroup doesn't appear in any scenario where the ...

Citigroup earnings are due Tuesday morning, and they’re expected to show a 28% decline in quarterly earnings from a year ago as lower interest rates crimp profits and the bank continues to work ...

Barclays analyst Jason Goldberg maintained a Hold rating on Citigroup (C – Research Report) today and set a price target of $70.00. The ...

By clicking ‘Sign Up’, you agree to receive newsletter from CoinDesk as well as other partner offers and accept our terms of ...

NEW YORK (Reuters) - Citigroup has promoted three senior healthcare investment bankers - Sumit Khedekar, Nishant Jadav and Michael Guarino - in the bank's push to win more deals in the industry ...